2022 MIPS Measure #476: Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia


Percentage of patients with an office visit within the measurement period and with a new diagnosis of clinically significant Benign Prostatic Hyperplasia who have International Prostate Symptoms Score (IPSS) or American Urological Association (AUA) Symptom Index (SI) documented at time of diagnosis and again 6-12 months later with an improvement of 3 points

Initial Population

Male patients with an initial diagnosis of benign prostatic hyperplasia 6 months prior to, or during the measurement period, and a urinary symptom score assessment within 1 month of initial diagnosis and a follow-up urinary symptom score assessment within 6-12 months, who had a qualifying visit during the measurement period


Equals Initial Population

Denominator Exclusions

  • Patients with urinary retention that starts within 1 year of initial BPH diagnosis.
  • Patients with an initial BPH diagnosis that starts during, or within 30 days of hospitalization.
  • Patients with a diagnosis of morbid obesity, or with a BMI Exam >40 before the follow up urinary symptom score.


Patients with a documented improvement of at least 3 points in their urinary symptom score during the measurement period

Numerator Exclusions

Not Applicable

Denominator Exceptions



CMS-Geriatrics-2022, CMS-Urology-2022, ecqm-2022, Internal Medicine, Obstetrics/Gynecology, Preventive Medicine, Quality-2022